Journals / Türk Nöroloji Dergisi / 2021 / Cilt: 27 - Sayı: 1

Corticosteroid-responsive Epilepsia Partialis Continua

Kortikosteroide Yanıtlı Epilepsiya Parsiyalis Kontinua

Pages
75–78
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In AED-resistant EPC, a short course of corticosteroid may be helpful.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Epilepsia partialis continua (EPC) is a rare form of status epilepticus and often refractory to antiepileptic drugs (AEDs).
📊
Key Findings & Data:Persistent seizure activity may increase pro-inflammatory biomarkers locally, which may respond to adjunctive corticosteroid treatment, especially in central nervous system (CNS) infections.
💡
Conclusion & Impact:In AED-resistant EPC, a short course of corticosteroid may be helpful.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Epilepsia partialis continua (EPC) is a rare form of status epilepticus and often refractory to antiepileptic drugs (AEDs). Persistent seizure activity may increase pro-inflammatory biomarkers locally, which may respond to adjunctive corticosteroid treatment, especially in central nervous system (CNS) infections. We report four children with refractory EPC and the effect of adjunctive corticosteroid in controlling EPC. The duration of EPC ranged between 3 days and 7 months. One patient had secondary generalized convulsive status epilepticus. Cranial computed tomography/magnetic resonance imaging was abnormal in three out of four patients; revealing old infarction in one, tuberculoma in one, and neurocysticercosis in one. Electroencephalography revealed spike and sharp wave discharges on the corresponding cerebral hemisphere. The EPC was refractory to 2-6 AEDs. Following corticosteroid treatment, EPC remitted in two patients with CNS infection, and those with infarction and cryptogenic EPC converted to discrete seizures. In AED-resistant EPC, a short course of corticosteroid may be helpful.

Özet

Epilepsiya parsiyalis kontinua (EPK) nadir görülen bir status epileptikus şeklidir ve sıklıkla antiepileptik ilaçlara (AEİ) dirençlidir. Sürekli nöbet aktivitesi, proenflamatuvar biyobelirteçleri lokal olarak artırabilir ve özellikle merkezi sinir sistemi (MSS) enfeksiyonlarında adjuvan kortikosteroid tedavisine yanıt verebilir. Bu yazıda refrakter EPK’si olan dört çocuğu ve EPK’yi kontrol etmede adjuvan kortikosteroidin etkisini bildirmek istedik. EPK süresi 3 gün ile 7 ay arasında değişiyordu. Bir hastada sekonder jeneralize konvülsif status epileptikus vardı. Kraniyal bilgisayarlı tomografi/manyetik rezonans görüntüleme dört hastadan üçünde anormaldi; bir hastada eski enfarkt, bir hastada tüberkülom ve diğer hastada nörosistiserkoz ile uyumlu lezyonlar mevcuttu. Elektroensefalografide, lezyon tarafındaki hemisferde diken ve keskin dalga deşarjları görüldü. EPK, 2-6 AEİ’ye dirençliydi. Kortikosteroid tedavisini takiben EPK; MSS enfeksiyonu olan iki hastada geriledi, enfarktı olan hastada ve kriptojenik EPK’li hastada birbirinden ayrı nöbetlere dönüştü. AEİ’ye dirençli EPK’de, kısa bir kortikosteroid kürünün tedavide faydası olabilir.

🔖

Cite This Article

MİSRA, U. K., KALİTA, J., PANDEY, P. C., CHAUDHARY, S. K., SİNGH, V. K. (2022). Corticosteroid-responsive Epilepsia Partialis Continua. Türk Nöroloji Dergisi, Cilt: 27 - Sayı: 1, 75–78. https://ajindex.com/articles/655040

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Mameniskiene R, Bast T, Bentes C, et al. Clinical course and variability of non-Rasmussen, nonstroke motor and sensory epilepsia partialis continua: a European survey and analysis of 65 cases. Epilepsia 2011;52:1168-1176
  2. Masuda H, Mori M, Ito S, Yagishita T, Kuwabara S. Steroid-responsive epilepsia partialis continua with anti-thyroid antibodies: a spectrum of hashimoto’s encephalopathy? Case Rep Neurol 2014;6:166-170
  3. Hart YM, Cortez M, Andermann F, et al. Medical treatment of Rasmussen’s syndrome (chronic encephalitis and epilepsy): effect of high-dose steroids or immunoglobulins in 19 patients. Neurology 1994;44:1030-1036
  4. Fejerman N, Di Blasi AM. Status epilepticus of benign partial epilepsies in children: report of two cases. Epilepsia 1987;28:351-355
  5. Mbizvo GK, Lentel IC, Leen C, et al. Epilepsia partialis continua complicated by disseminated tuberculosis and hemophagocytic lymphohistiocytosis: a case report. J Med Case Rep 2019;13:191
  6. Bahi-Buisson N, Villanueva V, Bulteau C, et al. Long term response to steroid therapy in Rasmussen encephalitis. Seizure 2007;16:485-492
  7. Zoorob RJ, Cender D. A different look at corticosteroids. Am Fam Physician 1998;58:443-450
  8. Del Brutto OH, Nash TE, White AC Jr, et al. Revised diagnostic criteria for neurocysticercosis. J Neurol Sci 2017;372:202-210
  9. Misra UK, Kalita J, Tripathi A, Kumar M. Oxidative and endoplasmic reticulum stress in tuberculous meningitis related seizures. Epilepsy Res 2019;156:106160
  10. Wilkinson RJ, Rohlwink U, Misra UK, et al. Tuberculous meningitis international research consortium. tubercuslous meningitis. Nat Rev Neurol 2017;13:581-598
  11. Asranna A, Sureshbabu S, Mittal G, et al. Abdominal epilepsia partialis continua in neurocysticercosis. Epileptic Disord 2019;21:302-306
  12. Ramos AB, Cruz RA, Villemarette-Pittman NR, Olejniczak PW, Mader EC Jr. Dexamethasone as abortive treatment for refractory seizures or status epilepticus in the inpatient setting. J Investig Med High Impact Case Rep 2019;7:2324709619848816.